Full-Time

Operational Quality Assurance Manager

Fixed-Term Contract

EOS imaging

EOS imaging

51-200 employees

Low-dose 3D orthopedic imaging system

No salary listed

Île-de-France, France

Hybrid

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Metrology
Quality Assurance (QA)

Get referred to EOS imaging

See people who can refer or advise you

Requirements
  • Higher education from a general engineering or quality engineering school.
  • At least 5 years of Quality Assurance experience in the medical-device industry, including products already on the market.
  • At least 2 years of team coordination and/or cross-functional management experience.
  • Fluency in English is essential.
  • Knowledge of ISO 13485, European Union Regulation 2017/745, and MDSAP or, alternatively, 21 CFR 820.
  • Ability to build effective relationships with internal and external stakeholders.
  • Autonomy and rigor.
  • Ability to work collaboratively, propose improvements, analyze issues, and engage in dialogue.
  • Proficiency in audit techniques.
Responsibilities
  • Maintain and ensure the effective operation of the Group Quality Management System in collaboration with the Quality and Regulatory Affairs Director.
  • Coordinate training for new employees on the Quality Management System.
  • Monitor quality indicators and contribute to process reviews and management reviews.
  • Manage quality documentation and assist other departments in drafting quality documents.
  • Prepare for and participate in internal and external audits and inspections, and follow up on related actions.
  • Act as management representative by delegation in the absence of the Quality and Regulatory Affairs Director, in accordance with the quality system and applicable regulatory requirements.
  • Participate in ongoing continuous-improvement initiatives and contribute to their follow-up.
  • Participate in supplier selection, evaluation, and monitoring.
  • Conduct supplier audits and ensure the progress and documentation of supplier nonconformities in collaboration with Procurement.
  • Monitor improvement actions and supplier nonconformity reports.
  • Support other departments in resolving Production and Service nonconformities.
  • Ensure company measuring equipment is identified and that verification and calibration activities are performed.
  • Maintain, validate, and record verification and calibration reports and metrology-provider certifications.
  • Assist other departments in preparing product documents, including Design Master Record and Device History Record documents, and review and approve those documents.
  • Perform quality impact analyses for product changes.
  • Release components and finished products.
  • Monitor the operational activities of the team based in Paris and Besançon.
  • Support employees in handling routine and complex quality matters.
  • Facilitate quality decision-making on matters requiring arbitration.
  • Coordinate and ensure continuity of the team's operational activities.
  • Participate in activity and priority review meetings.
Desired Qualifications
  • MDSAP knowledge is preferred; knowledge of 21 CFR 820 is an alternative.

EOS imaging makes imaging devices and software for orthopedics. Its EOS system provides low-dose, full-body 3D images in weight-bearing positions to measure skeletal alignment for diagnosis and surgical planning. The offering includes EOSedge and EOSapps, which enable safe imaging and specialized planning tools, and is supported by maintenance services. After its 2021 acquisition by Alphatec Holdings, the company aims to connect pre-operative imaging with intra-operative workflows to improve orthopedic outcomes and streamline the path from diagnosis to surgery.

Company Size

51-200

Company Stage

IPO

Headquarters

Paris, France

Founded

1989

Get referred to EOS imaging

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026: EOS revenue rebounded to $17 million, with demand described as strong.
  • Established EOS Insight accounts lifted implant revenue 32% within six months of go-live.
  • Alphatec kept 2026 guidance at $882 million, signaling continued investment in EOS.

What critics are saying

  • May 5, 2026: Alphatec cut EOS revenue guidance to $77 million after installation delays.
  • May 2026 securities investigations by Kirby McInerney and Pomerantz target Alphatec's EOS disclosures.
  • EOS's capital-sale model depends on hospital installations, creating quarter-to-quarter revenue volatility.

What makes EOS imaging unique

  • EOSedge delivers low-dose, weight-bearing full-body 3D imaging for spine planning.
  • EOS Insight ties imaging to implant adoption inside Alphatec's procedural workflow.
  • Nobel Prize-linked Charpak technology still anchors EOS's clinical credibility in orthopedics.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

2%

2 year growth

2%
Associated Press
Jun 10th, 2026
Alphatechs USA unveils Bluetooth school cafeteria scanners and pin pads at SNA ANC 2026

Alphatechs USA is unveiling new Bluetooth school cafeteria pin pads and scanners at SNA ANC 2026 in Charlotte, North Carolina. The company will showcase Bluetooth versions of its AlphaPad pin pad and AlphaScan scanner combo at booth 1747. The new AlphaPad-BT and AlphaScan-BT feature Bluetooth 5.2 and are compatible with Windows, MacOS, iPads, iPhones, Android devices, Chromebooks and Microsoft Surface. According to founder and CEO Chris Fructus, the wireless versions provide greater flexibility for busy cafeteria environments. The Southern California-based company also offers USB versions and stand-alone barcode scanners. All devices are FCC-approved, assembled in the US, and come with a three-year warranty and price match guarantee. The products work with all US and Canadian school cafeteria point-of-sale software.

Yahoo Finance
May 5th, 2026
Western Standard sold $18M in Alphatec before stock plunged 20% on earnings miss

Western Standard disclosed in an SEC filing that it sold 1,232,881 shares of Alphatec Holdings during the first quarter, an estimated $17.95 million trade based on quarterly average pricing. Following the sale, Alphatec represents 0.13% of Western Standard's reported US equity assets. The disclosure came shortly before Alphatec reported disappointing first-quarter results. Revenue reached $192 million, up 14% year-over-year but missing analyst projections by approximately 4%. Surgical revenue climbed 17% and case volumes increased 21%, whilst adjusted EBITDA hit $21 million with expanding margins. However, the company lowered parts of its full-year outlook, triggering a more than 20% drop in after-hours trading to around $8.12. As of 4 May 2026, shares were priced at $10.33, down 13.8% over one year.

Yahoo Finance
May 5th, 2026
Alphatec reports $33.9M Q1 loss as revenue of $192.1M misses forecasts

Alphatec Holdings, a Carlsbad, California-based medical equipment company, reported a first-quarter loss of $33.9 million, or 22 cents per share. Adjusted earnings came to less than one cent per share. The company posted revenue of $192.1 million, missing analyst expectations of $199.6 million from four analysts surveyed by Zacks. Alphatec expects full-year revenue of $882 million. Shares have fallen 51% since the beginning of the year. In Tuesday's trading, shares hit $10.23, down 15% over the past 12 months.

Yahoo Finance
Apr 21st, 2026
US growth companies with 61% insider ownership see earnings surge

Alphatec Holdings, a medical technology company specialising in spinal disorder treatments, is amongst growth companies with high insider ownership in the United States. The company has a market capitalisation of $1.68 billion and generates revenue of $764.16 million from its medical products segment. The US market has risen 3.6% in the past week and 39% over the year, with earnings expected to grow 16% annually. Growth companies with high insider ownership are attracting attention as insider stakes often signal confidence from those closest to the business. Clearfield, another featured company, forecasts earnings growth of 61.1% annually, significantly outpacing the broader market. The company recently turned profitable and expects fiscal 2026 sales between $160 million and $170 million. Substantial insider buying occurred over the past three months.

Yahoo Finance
Mar 28th, 2026
Alphatec VP sells $1.4M in shares, retains $22M stake amid routine trading pattern

Craig Hunsaker, executive vice president at Alphatec Holdings, sold 116,367 shares worth approximately $1.44 million, according to a SEC Form 4 filing. The sale represented 6.32% of his direct holdings, reducing his stake from 1.84 million to 1.73 million shares. The transaction exceeded Hunsaker's recent median sale of 80,438 shares but remained within his typical range of activity since April 2025. A portion of the sales (33,602 shares) were executed under a Rule 10b5-1 plan adopted in March 2025 for tax obligations related to vesting restricted stock units. Following the transaction, Hunsaker's remaining direct ownership is valued at approximately $22.21 million. Alphatec Holdings, which provides spinal surgery solutions, has a market capitalisation of $1.88 billion.